Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature.
Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature.
复制标题
DOI:
10.36141/svdld.v38i1.11271
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Patel DC
中科院分区:
文献类型:
--
作者:
Innabi A;Gomez-Manjarres D;Alzghoul BN;Chizinga M;Mehrad B;Patel DC
Acute exacerbation of interstitial lung disease is a serious and life-threatening event but little is known about its treatment. Cyclophosphamide has been proposed in randomized clinic trials as a treatment option in progressive cases of systemic sclerosis related interstitial lung disease. However, in acute exacerbation of interstitial lung disease, we found only small case series, and retrospective studies, mostly with no comparative groups which described the role of cyclophosphamide. Results of these studies showed mixed outcomes, with no robust evidence that cyclophosphamide adds any benefit in treating acute exacerbations of interstitial lung disease. More well-designed studies including randomized clinical trials are needed to better understand the role of cyclophosphamide during exacerbations of interstitial lung disease. In this review article, we summarize the current evidence on the use of cyclophosphamide in interstitial lung disease with a focus on the acute exacerbation events.
登录
查看更多内容
影响因子:
3.9
作者:
Leuschner G;Behr J
通讯作者:
Behr J
影响因子:
24.3
作者:
Ambrosini, V;Cancellieri, A;Poletti, V
通讯作者:
Poletti, V
DOI:
10.1164/rccm.200703-463pp
发表时间:
2007-10-01
影响因子:
24.7
作者:
Collard, Harold R.;Moore, Bethany B.;Martinez, Fernando J.
通讯作者:
Martinez, Fernando J.
DOI:
10.36141/svdld.v36i2.7181
发表时间:
2019-01-01
影响因子:
1.6
作者:
Aso, Shotaro;Matsui, Hiroki;Yasunaga, Hideo
通讯作者:
Yasunaga, Hideo
影响因子:
--
作者:
Hoyles, Rachel K.;Ellis, Ross W.;du Bois, Roland M.
通讯作者:
du Bois, Roland M.